Sprzęganie przeciwciała z polimerem wrażliwym
Adam
- 0
Sprzęganie przeciwciała z polimerem wrażliwym na temperaturę poprzez reakcję typu click on in situ w celu umożliwienia wzbogacenia biomarkerem w celu zwiększenia czułości diagnostycznej
Early analysis of infectious illnesses is likely one of the present prevalent challenges, particularly in low and restricted useful resource settings the place easy, quick, transportable, low cost, and delicate diagnostic approaches are wanted. Lateral stream immunoassay (LFIA) is a typical, speedy screening assay. Nevertheless, the low assay sensitivity limits the utility of LFIA for specimens with low pathogenic masses (early an infection levels).
Antibodies conjugated with stimulus-responsive polymers have been beforehand utilized to enhance assay sensitivity for detection of biomarkers at low concentrations. Nevertheless, the lack of antibody affinity after polymer conjugation stays a major problem. On this research, we developed poly(N-isopropylacrylamide-co-N-(2-hydroxyisopropyl)acrylamide-co-strained alkyne-isopropylacrylamide), a novel polymer for biomarker enrichment, by polymer conjugation after antibody-antigen recognition.
We employed and promoted the clicking chemistry in situ, to facilitate extremely particular conjugation between novel temperature-responsive polymers and antibody-antigen complexes. This technique might suppress the lower within the binding fixed related to polymer conjugation (>20-fold).
The conjugation was efficiently demonstrated in physique fluids comparable to urine and saliva. We achieved >5-fold antigen enrichment by way of thermal precipitation by conjugating polymers to the antibodies after antigen recognition. Concentrated biomarkers resulted in improved LFIA detection. This method can doubtlessly be utilized to enhance diagnostic exams for infectious illnesses in low and restricted useful resource settings.

PDCD7 antibody |
|||
70R-19176 | Fitzgerald | 50 ul | EUR 435 |
Description: Rabbit polyclonal PDCD7 antibody |
PDCD7 antibody |
|||
70R-6011 | Fitzgerald | 50 ug | EUR 467 |
Description: Rabbit polyclonal PDCD7 antibody raised against the N terminal of PDCD7 |
PDCD7 antibody |
|||
70R-6012 | Fitzgerald | 50 ug | EUR 467 |
Description: Rabbit polyclonal PDCD7 antibody raised against the middle region of PDCD7 |
Goat Anti-Mouse IgG-Cy3 Conjugate (Adsorbed with Bov, Ch, Gt, Gp, Ha, Hs, Hu, Rb, Sh) |
|||
40337-Cy3 | Alpha Diagnostics | 0.5 ml | EUR 263 |
PDCD7 Polyclonal Antibody |
|||
ES9220-100ul | ELK Biotech | 100ul | EUR 279 |
Description: A Rabbit Polyclonal antibody against PDCD7 from Human/Mouse. This antibody is tested and validated for WB, ELISA, WB, ELISA |
PDCD7 Polyclonal Antibody |
|||
ES9220-50ul | ELK Biotech | 50ul | EUR 207 |
Description: A Rabbit Polyclonal antibody against PDCD7 from Human/Mouse. This antibody is tested and validated for WB, ELISA, WB, ELISA |
Anti-PDCD7 antibody |
|||
STJ190378 | St John's Laboratory | 200 µl | EUR 197 |
Description: Unconjugated Rabbit polyclonal to PDCD7 |
Anti-PDCD7 antibody |
|||
STJ114027 | St John's Laboratory | 100 µl | EUR 277 |
Description: This gene encodes a 59 kDa protein that is associated with the U11 small nuclear ribonucleoprotein (snRNP), which is a component of the minor U12-type spliceosome responsible for catalyzing pre-mRNA splicing of U12-type introns. |
PDCD7 Polyclonal Antibody |
|||
ABP59857-003ml | Abbkine | 0.03ml | EUR 158 |
Description: A polyclonal antibody for detection of PDCD7 from Human, Mouse. This PDCD7 antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human PDCD7 protein at amino acid sequence of 300-380 |
PDCD7 Polyclonal Antibody |
|||
ABP59857-01ml | Abbkine | 0.1ml | EUR 289 |
Description: A polyclonal antibody for detection of PDCD7 from Human, Mouse. This PDCD7 antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human PDCD7 protein at amino acid sequence of 300-380 |
PDCD7 Polyclonal Antibody |
|||
ABP59857-02ml | Abbkine | 0.2ml | EUR 414 |
Description: A polyclonal antibody for detection of PDCD7 from Human, Mouse. This PDCD7 antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human PDCD7 protein at amino acid sequence of 300-380 |
anti- PDCD7 antibody |
|||
FNab06244 | FN Test | 100µg | EUR 505.25 |
Description: Antibody raised against PDCD7 |
Anti-PDCD7 antibody |
|||
PAab06244 | Lifescience Market | 100 ug | EUR 355 |
PDCD7 siRNA |
|||
20-abx928046 | Abbexa |
|
|
PDCD7 Rabbit pAb |
|||
A12133-100ul | Abclonal | 100 ul | EUR 308 |
PDCD7 Rabbit pAb |
|||
A12133-200ul | Abclonal | 200 ul | EUR 459 |
PDCD7 Rabbit pAb |
|||
A12133-20ul | Abclonal | 20 ul | EUR 183 |
PDCD7 Rabbit pAb |
|||
A12133-50ul | Abclonal | 50 ul | EUR 223 |
PDCD7 Blocking Peptide |
|||
DF9029-BP | Affbiotech | 1mg | EUR 195 |
Anti-PDCD7 (3H5) |
|||
YF-MA17111 | Abfrontier | 100 ug | EUR 363 |
Description: Mouse monoclonal to PDCD7 |
PDCD7 Blocking Peptide |
|||
33R-5695 | Fitzgerald | 100 ug | EUR 180 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of PDCD7 antibody, catalog no. 70R-6011 |
PDCD7 Blocking Peptide |
|||
33R-10177 | Fitzgerald | 100 ug | EUR 180 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of PDCD7 antibody, catalog no. 70R-6012 |
Cy3 Conjugated Avidin |
|||
BA1037 | BosterBio | 0.5ml | EUR 162 |
Human PDCD7 shRNA Plasmid |
|||
20-abx956791 | Abbexa |
|
|
PDCD7 ELISA KIT|Human |
|||
EF001632 | Lifescience Market | 96 Tests | EUR 689 |
PDCD7 Recombinant Protein (Rat) |
|||
RP219737 | ABM | 100 ug | Ask for price |
PDCD7 Recombinant Protein (Mouse) |
|||
RP160850 | ABM | 100 ug | Ask for price |
PDCD7 Recombinant Protein (Human) |
|||
RP082662 | ABM | 100 ug | Ask for price |
Programmed Cell Death 7 (PDCD7) Antibody |
|||
20-abx126336 | Abbexa |
|
|
Programmed Cell Death 7 (PDCD7) Antibody |
|||
20-abx114701 | Abbexa |
|
|
Programmed Cell Death 7 (PDCD7) Antibody |
|||
abx027477-400ul | Abbexa | 400 ul | EUR 523 |
Programmed Cell Death 7 (PDCD7) Antibody |
|||
abx027477-80l | Abbexa | 80 µl | EUR 286 |
Programmed Cell Death 7 (PDCD7) Antibody |
|||
abx236244-100ug | Abbexa | 100 ug | EUR 481 |
Programmed Cell Death 7 (PDCD7) Antibody |
|||
20-abx212468 | Abbexa |
|
|
Programmed Cell Death 7 (PDCD7) Antibody |
|||
20-abx212469 | Abbexa |
|
|
Monoclonal PDCD7 Antibody (monoclonal) (M01), Clone: 3H5 |
|||
APR08986G | Leading Biology | 0.1mg | EUR 484 |
Description: A Monoclonal antibody against Human PDCD7 (monoclonal) (M01). The antibodies are raised in mouse and are from clone 3H5. This antibody is applicable in WB, E |
Pdcd7 ORF Vector (Rat) (pORF) |
|||
ORF073247 | ABM | 1.0 ug DNA | EUR 506 |
PDCD7 ORF Vector (Human) (pORF) |
|||
ORF027555 | ABM | 1.0 ug DNA | EUR 405 |
Pdcd7 ORF Vector (Mouse) (pORF) |
|||
ORF053618 | ABM | 1.0 ug DNA | EUR 506 |
PDCD7 sgRNA CRISPR Lentivector set (Human) |
|||
K1616501 | ABM | 3 x 1.0 ug | EUR 339 |
Pdcd7 sgRNA CRISPR Lentivector set (Mouse) |
|||
K4825601 | ABM | 3 x 1.0 ug | EUR 339 |
Pdcd7 sgRNA CRISPR Lentivector set (Rat) |
|||
K6340301 | ABM | 3 x 1.0 ug | EUR 339 |
Goat Anti-Rabbit IgG Secondary Antibody Cy3 Conjugated |
|||
L30111 | SAB | 1.0 ml | EUR 112 |
Goat Anti-Human IgG Secondary Antibody Cy3 Conjugated |
|||
L30211 | SAB | 1.0 ml | EUR 112 |
Goat Anti-Mouse IgG Secondary Antibody Cy3 Conjugated |
|||
L30311 | SAB | 1.0 ml | EUR 112 |
PDCD7 sgRNA CRISPR Lentivector (Human) (Target 1) |
|||
K1616502 | ABM | 1.0 ug DNA | EUR 154 |
PDCD7 sgRNA CRISPR Lentivector (Human) (Target 2) |
|||
K1616503 | ABM | 1.0 ug DNA | EUR 154 |
PDCD7 sgRNA CRISPR Lentivector (Human) (Target 3) |
|||
K1616504 | ABM | 1.0 ug DNA | EUR 154 |
Pdcd7 sgRNA CRISPR Lentivector (Mouse) (Target 1) |
|||
K4825602 | ABM | 1.0 ug DNA | EUR 154 |
Pdcd7 sgRNA CRISPR Lentivector (Mouse) (Target 2) |
|||
K4825603 | ABM | 1.0 ug DNA | EUR 154 |
Pdcd7 sgRNA CRISPR Lentivector (Mouse) (Target 3) |
|||
K4825604 | ABM | 1.0 ug DNA | EUR 154 |
Pdcd7 sgRNA CRISPR Lentivector (Rat) (Target 1) |
|||
K6340302 | ABM | 1.0 ug DNA | EUR 154 |
Pdcd7 sgRNA CRISPR Lentivector (Rat) (Target 2) |
|||
K6340303 | ABM | 1.0 ug DNA | EUR 154 |
Pdcd7 sgRNA CRISPR Lentivector (Rat) (Target 3) |
|||
K6340304 | ABM | 1.0 ug DNA | EUR 154 |
PDCD7 Protein Vector (Rat) (pPB-C-His) |
|||
PV292986 | ABM | 500 ng | EUR 603 |
PDCD7 Protein Vector (Rat) (pPB-N-His) |
|||
PV292987 | ABM | 500 ng | EUR 603 |
PDCD7 Protein Vector (Rat) (pPM-C-HA) |
|||
PV292988 | ABM | 500 ng | EUR 603 |
PDCD7 Protein Vector (Rat) (pPM-C-His) |
|||
PV292989 | ABM | 500 ng | EUR 603 |
PDCD7 Protein Vector (Human) (pPB-C-His) |
|||
PV110218 | ABM | 500 ng | EUR 552 |
PDCD7 Protein Vector (Human) (pPB-N-His) |
|||
PV110219 | ABM | 500 ng | EUR 552 |
PDCD7 Protein Vector (Human) (pPM-C-HA) |
|||
PV110220 | ABM | 500 ng | EUR 552 |
PDCD7 Protein Vector (Human) (pPM-C-His) |
|||
PV110221 | ABM | 500 ng | EUR 552 |
PDCD7 Protein Vector (Mouse) (pPB-C-His) |
|||
PV214470 | ABM | 500 ng | EUR 603 |
PDCD7 Protein Vector (Mouse) (pPB-N-His) |
|||
PV214471 | ABM | 500 ng | EUR 603 |
PDCD7 Protein Vector (Mouse) (pPM-C-HA) |
|||
PV214472 | ABM | 500 ng | EUR 603 |
PDCD7 Protein Vector (Mouse) (pPM-C-His) |
|||
PV214473 | ABM | 500 ng | EUR 603 |
PDCD7 3'UTR GFP Stable Cell Line |
|||
TU067617 | ABM | 1.0 ml | EUR 1394 |
Pdcd7 3'UTR Luciferase Stable Cell Line |
|||
TU215980 | ABM | 1.0 ml | Ask for price |
Pdcd7 3'UTR GFP Stable Cell Line |
|||
TU265980 | ABM | 1.0 ml | Ask for price |
PDCD7 3'UTR Luciferase Stable Cell Line |
|||
TU017617 | ABM | 1.0 ml | EUR 1394 |
Pdcd7 3'UTR Luciferase Stable Cell Line |
|||
TU116090 | ABM | 1.0 ml | Ask for price |
Pdcd7 3'UTR GFP Stable Cell Line |
|||
TU166090 | ABM | 1.0 ml | Ask for price |
Cy3 Conjugated anti-Mouse IgG SABC Kit |
|||
SA1072 | BosterBio | 1 kit | EUR 355 |
Cy3 Conjugated anti-Mouse IgM SABC Kit |
|||
SA1073 | BosterBio | 1 kit | EUR 375 |
Cy3 Conjugated anti-Rabbit IgG SABC Kit |
|||
SA1074 | BosterBio | 1 kit | EUR 355 |
Cy3 Conjugated anti-Goat IgG SABC Kit |
|||
SA1076 | BosterBio | 1 kit | EUR 355 |
Cy3 Conjugated anti-Human IgG SABC Kit |
|||
SA1078 | BosterBio | 1 kit | EUR 355 |
Cy3 Conjugated anti-Rat IgG SABC Kit |
|||
SA1079 | BosterBio | 1 kit | EUR 355 |
Human Programmed Cell Death 7 (PDCD7) ELISA Kit |
|||
abx382117-96tests | Abbexa | 96 tests | EUR 911 |
Cy3 Conjugated Goat Anti-Mouse IgG (H+L) secondary antibody |
|||
BA1031 | BosterBio | 0.5ml | EUR 182 |
Cy3 Conjugated Goat Anti-Rabbit IgG (H+L) secondary antibody |
|||
BA1032 | BosterBio | 0.5ml | EUR 182 |
Cy3 Conjugated Rabbit Anti-Goat IgG (H+L) secondary antibody |
|||
BA1034 | BosterBio | 0.5ml | EUR 182 |
Cy3 Conjugated Rabbit Anti-Human IgG (H+L) secondary antibody |
|||
BA1035 | BosterBio | 0.5ml | EUR 182 |
Cy3 tertrazine [Cy3 tertrazine] |
|||
910 | AAT Bioquest | 1 mg | EUR 219 |
Goat Anti-Rabbit IgG(H+L) CY3–conjugated |
|||
S0011 | Affbiotech | 200ul | EUR 304 |
Goat Anti-Mouse IgG(H+L) CY3–conjugated |
|||
S0012 | Affbiotech | 200ul | EUR 304 |
Mouse Programmed cell death protein 7, Pdcd7 ELISA KIT |
|||
ELI-43163m | Lifescience Market | 96 Tests | EUR 865 |
Human Programmed cell death protein 7, PDCD7 ELISA KIT |
|||
ELI-35680h | Lifescience Market | 96 Tests | EUR 824 |
CY3 |
|||
HY-D0822 | MedChemExpress | 5mg | EUR 354 |
Fluorescein Isothiocyanate (Cy3) Monoclonal Antibody (Pan-species), Cy3 |
|||
4-MAO843Ge21-Cy3 | Cloud-Clone |
|
|
Description: A Mouse monoclonal antibody against Pan-species Fluorescein Isothiocyanate (Cy3). This antibody is labeled with Cy3. |
Metoda selektywnej koniugacji N-końca poszerza okno terapeutyczne koniugatów przeciwciało-lek poprzez poprawę tolerancji i stabilności
Antibody-drug conjugates (ADCs) are focused therapeutic brokers that deal with cancers by selective supply of extremely potent cytotoxic medicine to tumor cells by way of cancer-specific antibodies. Nevertheless, their medical profit is restricted by off-target toxicity and slim therapeutic home windows. To beat these limitations, now we have utilized reductive alkylation to develop a brand new kind of ADC that has cytotoxic medicine conjugated to the N-terminal of an antibody by way of amine bonds launched by way of reductive alkylation reactions (NTERM). To check whether or not the NTERM-conjugated ADCs can widen therapeutic home windows, we synthesized three totally different ADCs by conjugating trastuzumab and monomethyl auristatin-F utilizing three totally different strategies, and in contrast their stability, efficacy, and toxicity.
The NTERM-conjugated ADC was extra steady in vitro and in vivo than the thiol-conjugated and the lysine-conjugated ADCs. The NTERM-conjugated ADC confirmed decrease toxicity in comparison with different ADCs, whereas its efficacy was akin to that of the thiol-conjugated ADC and higher than that of the lysine-conjugated ADC. These outcomes recommend that the NTERM conjugation technique might widen the therapeutic window of ADCs by enhancing its stability and lowering toxicity.
Uniwersalny check immunologiczny ze znacznikiem SERS do wykrywania bakterii chorobotwórczych w oparciu o separację Fe 3 O 4 @ Au-aptamer i rozpoznawanie orientacji przeciwciało-białko A
Speedy, dependable and delicate detection strategies for pathogenic micro organism are strongly demanded. Herein, we proposed a magnetically assisted floor enhanced Raman scattering (SERS)-label immunoassay for the delicate detection of micro organism by utilizing a common method based mostly on free antibody labelling and staphylococcus proteins A (PA)-SERS tags orientation recognition. The SERS biosensor consists of two purposeful nanomaterials: aptamer-conjugated Fe3O4@Au magnetic nanoparticles (MNPs) as magnetic SERS platform for pathogen enrichment and PA modified-SERS tags (Au@DTNB@PA) as a common probe for goal micro organism quantitative detection. After goal micro organism enriched, free antibody was used to particular marking goal micro organism and supplied quite a few Fc fragment, which might information the PA-SERS tags orientation-dependent binding.
With this technique, Fe3O4@Au/micro organism/SERS tags sandwich immunocomplexes for many micro organism (anticipate a number of species of Staphylococcus) had been straightforward constructed. The bounds of detection (LODs) of the proposed assay had been discovered to be 10, 10, and 25 cells/mL for 3 widespread pathogens Escherichia coli (E. coli), Listeria monocytogenes (L. mono), and Salmonella typhimurium (S. typhi), respectively, in actual meals samples. The common technique additionally displays the benefits of speedy, sturdy, and straightforward to function, suggesting its nice potential for meals security monitoring and infectious illnesses analysis.
Zwiększenie wydajności poprzez tworzenie wzoru składania gradientu cząstek immunosensora elektrochemiluminescencyjnego utworzonego za pomocą magnetolitografii w oznaczaniu albuminy surowicy ludzkiej
Gradient properties facilitate the correlation of chemical and bodily options of particles on the construction and adherent destiny. Herein, efficiency enhancement is explored by particle gradient meeting patterning (PGAP) shaped with magnetic discipline gradient (MFG) by magnetolithography (ML) within the electrochemiluminescence (ECL) measurement. Magnetic Fe3O4 nanoparticles had been chosen as nanocarriers and coated with a SiO2 layer for immobilization of main antibodies. CdTe quantum dots with protein G coatings had been chosen as sign labels and conjugated with secondary antibodies. Magnetized 500-nm pillar, 1 μm- and three μm-line arrays of nickel had been positioned behind the working electrode modifying the sandwich-structured ECL immunosensor to type numerous PGAPs.
A efficiency enhancement of ca. 2.Four instances was noticed when evaluating the PGAP-free immunosensor to the researched gradient immunosensor, shaped with a magnetized Three μm-line array of nickel. This concludes that the sensitivity of an ECL immunosensor has been enhanced as a result of PGAP properties. When the immunosensor with PGAP properties was used to quantify human serum albumin, it exhibited a large linear vary (10-480 ng/mL), and a restrict of detection of 10 ng/mL. PGAP properties, shaped with MFG by ML, supplies a easy technique to enhance the ECL efficiency.
Ocena [Cys (ATTO 488) 8] Dermorphin-NH2 jako nowego narzędzia do badania receptorów peptydowych opioidowych μ
The μ-opioid peptide (MOP) receptor is a member of the opioid receptor household and an vital medical goal for analgesia. Measuring MOP receptor location and monitoring its turnover historically used radiolabels or antibodies with attendant issues of utility of radiolabels in complete cells and poor antibody selectivity. To deal with these points now we have synthesized and characterised a novel ATTO488 based mostly fluorescent Dermorphin analogue; [Cys(ATTO 488)8]Dermorphin-NH2 (DermATTO488).
We initially assessed the binding profile of DermATTO488 in HEK cells expressing human MOP and CHO cells expressing human MOP, δ-opioid peptide (DOP), κ-opioid peptide (KOP) and Nociceptin/Orphanin FQ peptide (NOP) receptors utilizing radioligand binding. Purposeful exercise of the conjugated peptide was assessed by measuring (i) the flexibility of the ligand to have interaction G-protein by measuring the flexibility to stimulate GTPγ[35S] binding and (ii) the flexibility to stimulate phosphorylation of ERK1/2. Receptor location was visualised utilizing confocal scanning laser microscopy.
Dermorphin and DermATTO488 sure to HEKMOP (pKi: 8.29 and seven.00; p<0.05), CHOMOP (pKi: 9.26 and eight.12; p<0.05) and CHODOP (pKi: 7.03 and seven.16; p>0.05). Each ligands had been inactive at KOP and NOP. Dermorphin and DermATTO488 stimulated the binding of GTPγ[35S] with comparable pEC50 (7.84 and seven.62; p>0.05) and Emax (1.52 and 1.34fold p>0.05) values. Furthermore, Dermorphin and DermATTO488 produced a monophasic stimulation of ERK1/2 phosphorylation peaking at 5mins (6.98 and seven.64-fold; p>0.05).
Lastly, in confocal microscopy DermATTO488 sure to recombinant MOP receptors on CHO and HEK cells in a focus dependent method that might be blocked by pre-incubation with unlabelled Dermorphin or Naloxone. Collectively, addition to ATTO488 to Dermorphin produced a ligand not dissimilar to Dermorphin; with ~10fold selectivity over DOP. This new ligand DermATTO488 retained purposeful exercise and might be used to visualise MOP receptor location.
CXXC5 Antibody |
|||
1-CSB-PA741975LA01HU | Cusabio |
|
|
Description: A polyclonal antibody against CXXC5. Recognizes CXXC5 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC; Recommended dilution: IHC:1:20-1:200 |
CXXC5 Antibody |
|||
1-CSB-PA806953 | Cusabio |
|
|
Description: A polyclonal antibody against CXXC5. Recognizes CXXC5 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:2000-1:5000, IHC:1:50-1:200 |
CXXC5 Antibody |
|||
DF12378 | Affbiotech | 200ul | EUR 304 |
Description: CXXC5 antibody detects endogenous levels of CXXC5. |
CXXC5 Antibody |
|||
6111-002mg | ProSci | 0.02 mg | EUR 171.82 |
Description: CXXC5 Antibody: CXXC5 is zinc finger protein closely related to the DVL1-binding protein CXXC4 (also known as Idax), and like CXXC4 is thought to modulate the Wnt signaling pathway during development. CXXC5 is upregulated in neural stem cells upon BMP4 stimulation, leading to decreased levels of the Wnt-signaling target AXIN2 and facilitated the response of the stem cells to Wnt3a. Recent reports suggest CXXC5 transcription is activated by the Wilms tumor 1 (WT1) transcription factor, and together are involved in the WNT/beta-catenin pathway and play a role in embryonic kidney development. |
CXXC5 Antibody |
|||
6111-01mg | ProSci | 0.1 mg | EUR 436.42 |
Description: CXXC5 Antibody: CXXC5 is zinc finger protein closely related to the DVL1-binding protein CXXC4 (also known as Idax), and like CXXC4 is thought to modulate the Wnt signaling pathway during development. CXXC5 is upregulated in neural stem cells upon BMP4 stimulation, leading to decreased levels of the Wnt-signaling target AXIN2 and facilitated the response of the stem cells to Wnt3a. Recent reports suggest CXXC5 transcription is activated by the Wilms tumor 1 (WT1) transcription factor, and together are involved in the WNT/beta-catenin pathway and play a role in embryonic kidney development. |
CXXC Finger Protein 5 (CXXC5) Antibody (HRP) |
|||
20-abx307796 | Abbexa |
|
|
CXXC5 Polyclonal Antibody |
|||
A65418 | EpiGentek | 100 µg | EUR 570.55 |
Description: The best epigenetics products |
Polyclonal CXXC5 Antibody |
|||
APR06686G | Leading Biology | 0.1 mg | EUR 659 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human CXXC5 . This antibody is tested and proven to work in the following applications: |
anti- CXXC5 antibody |
|||
FNab02113 | FN Test | 100µg | EUR 505.25 |
Description: Antibody raised against CXXC5 |
Anti-CXXC5 antibody |
|||
PAab02113 | Lifescience Market | 100 ug | EUR 355 |
GAPDH Antibody - HRP |
|||
T0004-HRP | Affbiotech | 1ml | EUR 920 |
Description: GAPDH Mouse Monoclonal antibody detects endogenous levels of total GAPDH protein. |
beta-Actin Antibody - HRP |
|||
T0022-HRP | Affbiotech | 1ml | EUR 920 |
Description: beta-Actin Mouse Monoclonal antibody detects endogenous levels of total beta-Actin protein. |
CXXC5 siRNA |
|||
20-abx913288 | Abbexa |
|
|
CXXC5 siRNA |
|||
20-abx913289 | Abbexa |
|
|
CXXC5 siRNA |
|||
20-abx901358 | Abbexa |
|
|
pOTB7-CXXC5 |
|||
PVT18864 | Lifescience Market | 2 ug | EUR 231 |
CXXC5 Peptide |
|||
6111P | ProSci | 0.05 mg | EUR 164.75 |
Description: (NT) CXXC5 peptide |
ACE2 Antibody (HRP) |
|||
3217-HRP-002mg | ProSci | 0.02 mg | EUR 191.42 |
Description: ACE2 Antibody: Angiotensin-converting enzyme 2 (ACE2) plays a central role in vascular, renal, and myocardial physiology. In contrast to its homolog ACE, ACE2 expression is restricted to heart, kidney, and testis. Recently. ACE2 has also been shown to be a functional receptor of the SARS coronavirus. Homology modeling shows 2019-nCoV has a similar receptor-binding domain structure as SARS-CoV, which suggests COVID-19 (2019-nCoV) may use ACE2 as a receptor in humans for infection. The normal function of ACE2 is to convert the inactive vasoconstrictor angiotensin I (AngI) to Ang1-9 and the active form AngII to Ang1-7, unlike ACE, which converts AngI to AngII. While the role of these vasoactive peptides is not well understood, lack of ACE2 expression in ace2-/ace2- mice leads to severely reduced cardiac contractility, indicating its importance in regulating heart function. |
ACE2 Antibody (HRP) |
|||
3217-HRP-01mg | ProSci | 0.1 mg | EUR 495.22 |
Description: ACE2 Antibody: Angiotensin-converting enzyme 2 (ACE2) plays a central role in vascular, renal, and myocardial physiology. In contrast to its homolog ACE, ACE2 expression is restricted to heart, kidney, and testis. Recently. ACE2 has also been shown to be a functional receptor of the SARS coronavirus. Homology modeling shows 2019-nCoV has a similar receptor-binding domain structure as SARS-CoV, which suggests COVID-19 (2019-nCoV) may use ACE2 as a receptor in humans for infection. The normal function of ACE2 is to convert the inactive vasoconstrictor angiotensin I (AngI) to Ang1-9 and the active form AngII to Ang1-7, unlike ACE, which converts AngI to AngII. While the role of these vasoactive peptides is not well understood, lack of ACE2 expression in ace2-/ace2- mice leads to severely reduced cardiac contractility, indicating its importance in regulating heart function. |
Biotin [HRP] |
|||
DAG3197-HRP | Creative Diagnostics | 1mg | EUR 429 |
CXXC5 cloning plasmid |
|||
CSB-CL741975HU1-10ug | Cusabio | 10ug | EUR 233 |
Description: A cloning plasmid for the CXXC5 gene. |
CXXC5 cloning plasmid |
|||
CSB-CL741975HU2-10ug | Cusabio | 10ug | EUR 381 |
Description: A cloning plasmid for the CXXC5 gene. |
CXXC5 Blocking Peptide |
|||
DF12378-BP | Affbiotech | 1mg | EUR 195 |
Polyclonal CXXC5 Antibody (N-Terminus) |
|||
APR02864G | Leading Biology | 0.05mg | EUR 484 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human CXXC5 (N-Terminus). This antibody is tested and proven to work in the following applications: |
Polyclonal CXXC5 Antibody (N-Term) |
|||
APR04949G | Leading Biology | 0.1ml | EUR 484 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human CXXC5 (N-Term). This antibody is tested and proven to work in the following applications: |
Vitamine B9 [HRP] |
|||
DAGDT1440-HRP | Creative Diagnostics | 1mg | EUR 1105 |
Vitamine B12 [HRP] |
|||
DAGT5413-HRP | Creative Diagnostics | 1mg | EUR 975 |
HRP-IgG Conjugation Kit |
|||
55R-HRP | Fitzgerald | 1 mg | EUR 705 |
Description: HRP conjugation kit for all types of IgG |
CXXC Finger Protein 5 (CXXC5) Antibody |
|||
20-abx301437 | Abbexa |
|
|
CXXC Finger Protein 5 (CXXC5) Antibody |
|||
20-abx241495 | Abbexa |
|
|
CXXC Finger Protein 5 (CXXC5) Antibody |
|||
20-abx241758 | Abbexa |
|
|
CXXC Finger Protein 5 (CXXC5) Antibody |
|||
abx232113-100ug | Abbexa | 100 ug | EUR 481 |
Polyclonal Cxxc5 Antibody - N-terminal region |
|||
APR01390G | Leading Biology | 0.05mg | EUR 528 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human Cxxc5 - N-terminal region. This antibody is tested and proven to work in the following applications: |
Mouse CXXC5 shRNA Plasmid |
|||
20-abx976120 | Abbexa |
|
|
Rat CXXC5 shRNA Plasmid |
|||
20-abx988513 | Abbexa |
|
|
Human CXXC5 shRNA Plasmid |
|||
20-abx959808 | Abbexa |
|
|
CXXC5 ELISA KIT|Human |
|||
EF008936 | Lifescience Market | 96 Tests | EUR 689 |
CXXC5 Recombinant Protein (Mouse) |
|||
RP126935 | ABM | 100 ug | Ask for price |
CXXC5 Recombinant Protein (Rat) |
|||
RP196946 | ABM | 100 ug | Ask for price |
CXXC5 Recombinant Protein (Human) |
|||
RP008518 | ABM | 100 ug | Ask for price |
CXXC5 Recombinant Protein (Human) |
|||
RP008521 | ABM | 100 ug | Ask for price |
pGEM-CXXC5-m vector |
|||
PVT12059 | Lifescience Market | 2 ug | EUR 308 |
KAT7 Antibody, HRP conjugated |
|||
1-CSB-PA03865B0Rb | Cusabio |
|
|
Description: A polyclonal antibody against KAT7. Recognizes KAT7 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA |
TUBB3 Antibody, HRP conjugated |
|||
1-CSB-PA03874B0Rb | Cusabio |
|
|
Description: A polyclonal antibody against TUBB3. Recognizes TUBB3 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA |
TUBB3 Antibody, HRP conjugated |
|||
1-CSB-PA03879B0Rb | Cusabio |
|
|
Description: A polyclonal antibody against TUBB3. Recognizes TUBB3 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA |
TMEM109 Antibody, HRP conjugated |
|||
1-CSB-PA03899B0Rb | Cusabio |
|
|
Description: A polyclonal antibody against TMEM109. Recognizes TMEM109 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA |
DNAJB1 Antibody, HRP conjugated |
|||
1-CSB-PA03934B0Rb | Cusabio |
|
|
Description: A polyclonal antibody against DNAJB1. Recognizes DNAJB1 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA |
virD2 Antibody, HRP conjugated |
|||
1-CSB-PA03944B0Rb | Cusabio |
|
|
Description: A polyclonal antibody against virD2. Recognizes virD2 from Agrobacterium tumefaciens. This antibody is HRP conjugated. Tested in the following application: ELISA |
RELA Antibody, HRP conjugated |
|||
1-CSB-PA03987B0Rb | Cusabio |
|
|
Description: A polyclonal antibody against RELA. Recognizes RELA from Human. This antibody is HRP conjugated. Tested in the following application: ELISA |
AFG3L2 Antibody, HRP conjugated |
|||
1-CSB-PA04005B0Rb | Cusabio |
|
|
Description: A polyclonal antibody against AFG3L2. Recognizes AFG3L2 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA |
SNX22 Antibody, HRP conjugated |
|||
1-CSB-PA04059B0Rb | Cusabio |
|
|
Description: A polyclonal antibody against SNX22. Recognizes SNX22 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA |
GPR161 Antibody, HRP conjugated |
|||
1-CSB-PA04114B0Rb | Cusabio |
|
|
Description: A polyclonal antibody against GPR161. Recognizes GPR161 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA |
SARS Antibody, HRP conjugated |
|||
1-CSB-PA04145B0Rb | Cusabio |
|
|
Description: A polyclonal antibody against SARS. Recognizes SARS from Human. This antibody is HRP conjugated. Tested in the following application: ELISA |
PFN1 Antibody, HRP conjugated |
|||
1-CSB-PA04154B0Rb | Cusabio |
|
|
Description: A polyclonal antibody against PFN1. Recognizes PFN1 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA |
TUBA1B Antibody, HRP conjugated |
|||
1-CSB-PA04189B0Rb | Cusabio |
|
|
Description: A polyclonal antibody against TUBA1B. Recognizes TUBA1B from Human. This antibody is HRP conjugated. Tested in the following application: ELISA |
SLC6A7 Antibody, HRP conjugated |
|||
1-CSB-PA04209B0Rb | Cusabio |
|
|
Description: A polyclonal antibody against SLC6A7. Recognizes SLC6A7 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA |
RPS14 Antibody, HRP conjugated |
|||
1-CSB-PA04255B0Rb | Cusabio |
|
|
Description: A polyclonal antibody against RPS14. Recognizes RPS14 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA |
HNRNPH1 Antibody, HRP conjugated |
|||
1-CSB-PA04264B0Rb | Cusabio |
|
|
Description: A polyclonal antibody against HNRNPH1. Recognizes HNRNPH1 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA |
TALDO1 Antibody, HRP conjugated |
|||
1-CSB-PA04275B0Rb | Cusabio |
|
|
Description: A polyclonal antibody against TALDO1. Recognizes TALDO1 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA |
AKAP17A Antibody, HRP conjugated |
|||
1-CSB-PA04299B0Rb | Cusabio |
|
|
Description: A polyclonal antibody against AKAP17A. Recognizes AKAP17A from Human. This antibody is HRP conjugated. Tested in the following application: ELISA |
PTDSS1 Antibody, HRP conjugated |
|||
1-CSB-PA04305B0Rb | Cusabio |
|
|
Description: A polyclonal antibody against PTDSS1. Recognizes PTDSS1 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA |
RAC1 Antibody, HRP conjugated |
|||
1-CSB-PA04329B0Rb | Cusabio |
|
|
Description: A polyclonal antibody against RAC1. Recognizes RAC1 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA |
ABL1 Antibody, HRP conjugated |
|||
1-CSB-PA04355B0Rb | Cusabio |
|
|
Description: A polyclonal antibody against ABL1. Recognizes ABL1 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA |
GTPBP6 Antibody, HRP conjugated |
|||
1-CSB-PA04439B0Rb | Cusabio |
|
|
Description: A polyclonal antibody against GTPBP6. Recognizes GTPBP6 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA |
TAX1BP3 Antibody, HRP conjugated |
|||
1-CSB-PA04445B0Rb | Cusabio |
|
|
Description: A polyclonal antibody against TAX1BP3. Recognizes TAX1BP3 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA |
FCGR2A Antibody, HRP conjugated |
|||
1-CSB-PA04459B0Rb | Cusabio |
|
|
Description: A polyclonal antibody against FCGR2A. Recognizes FCGR2A from Human. This antibody is HRP conjugated. Tested in the following application: ELISA |
JUND Antibody, HRP conjugated |
|||
1-CSB-PA04469B0Rb | Cusabio |
|
|
Description: A polyclonal antibody against JUND. Recognizes JUND from Human. This antibody is HRP conjugated. Tested in the following application: ELISA |
EFCAB14 Antibody, HRP conjugated |
|||
1-CSB-PA04499B0Rb | Cusabio |
|
|
Description: A polyclonal antibody against EFCAB14. Recognizes EFCAB14 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA |
CHMP2A Antibody, HRP conjugated |
|||
1-CSB-PA04524B0Rb | Cusabio |
|
|
Description: A polyclonal antibody against CHMP2A. Recognizes CHMP2A from Human. This antibody is HRP conjugated. Tested in the following application: ELISA |
RBPMS Antibody, HRP conjugated |
|||
1-CSB-PA04569B0Rb | Cusabio |
|
|
Description: A polyclonal antibody against RBPMS. Recognizes RBPMS from Human. This antibody is HRP conjugated. Tested in the following application: ELISA |
PIN1 Antibody, HRP conjugated |
|||
1-CSB-PA04619B0Rb | Cusabio |
|
|
Description: A polyclonal antibody against PIN1. Recognizes PIN1 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA |
LASP1 Antibody, HRP conjugated |
|||
1-CSB-PA04629B0Rb | Cusabio |
|
|
Description: A polyclonal antibody against LASP1. Recognizes LASP1 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA |
MT3 Antibody, HRP conjugated |
|||
1-CSB-PA04639B0Rb | Cusabio |
|
|
Description: A polyclonal antibody against MT3. Recognizes MT3 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA |
UQCRFS1 Antibody, HRP conjugated |
|||
1-CSB-PA04645B0Rb | Cusabio |
|
|
Description: A polyclonal antibody against UQCRFS1. Recognizes UQCRFS1 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA |
SLC6A8 Antibody, HRP conjugated |
|||
1-CSB-PA04679B0Rb | Cusabio |
|
|
Description: A polyclonal antibody against SLC6A8. Recognizes SLC6A8 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA |
KARS Antibody, HRP conjugated |
|||
1-CSB-PA04689B0Rb | Cusabio |
|
|
Description: A polyclonal antibody against KARS. Recognizes KARS from Human. This antibody is HRP conjugated. Tested in the following application: ELISA |
CFL1 Antibody, HRP conjugated |
|||
1-CSB-PA04709B0Rb | Cusabio |
|
|
Description: A polyclonal antibody against CFL1. Recognizes CFL1 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA |
TMED9 Antibody, HRP conjugated |
|||
1-CSB-PA04804B0Rb | Cusabio |
|
|
Description: A polyclonal antibody against TMED9. Recognizes TMED9 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA |
MRPL9 Antibody, HRP conjugated |
|||
1-CSB-PA04864B0Rb | Cusabio |
|
|
Description: A polyclonal antibody against MRPL9. Recognizes MRPL9 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA |
PDCD6 Antibody, HRP conjugated |
|||
1-CSB-PA04874B0Rb | Cusabio |
|
|
Description: A polyclonal antibody against PDCD6. Recognizes PDCD6 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA |
MAP2K2 Antibody, HRP conjugated |
|||
1-CSB-PA04909B0Rb | Cusabio |
|
|
Description: A polyclonal antibody against MAP2K2. Recognizes MAP2K2 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA |
DUOXA1 Antibody, HRP conjugated |
|||
1-CSB-PA04949B0Rb | Cusabio |
|
|
Description: A polyclonal antibody against DUOXA1. Recognizes DUOXA1 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA |
COMMD4 Antibody, HRP conjugated |
|||
1-CSB-PA04965B0Rb | Cusabio |
|
|
Description: A polyclonal antibody against COMMD4. Recognizes COMMD4 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA |
SUMO2 Antibody, HRP conjugated |
|||
1-CSB-PA05009B0Rb | Cusabio |
|
|
Description: A polyclonal antibody against SUMO2. Recognizes SUMO2 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA |
HSPA5 Antibody, HRP conjugated |
|||
1-CSB-PA05027B0Rb | Cusabio |
|
|
Description: A polyclonal antibody against HSPA5. Recognizes HSPA5 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA |
CNPY2 Antibody, HRP conjugated |
|||
1-CSB-PA05034B0Rb | Cusabio |
|
|
Description: A polyclonal antibody against CNPY2. Recognizes CNPY2 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA |
TMED2 Antibody, HRP conjugated |
|||
1-CSB-PA05049B0Rb | Cusabio |
|
|
Description: A polyclonal antibody against TMED2. Recognizes TMED2 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA |
LYPLA2 Antibody, HRP conjugated |
|||
1-CSB-PA05074B0Rb | Cusabio |
|
|
Description: A polyclonal antibody against LYPLA2. Recognizes LYPLA2 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA |
BTBD2 Antibody, HRP conjugated |
|||
1-CSB-PA05095B0Rb | Cusabio |
|
|
Description: A polyclonal antibody against BTBD2. Recognizes BTBD2 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA |
ANAPC5 Antibody, HRP conjugated |
|||
1-CSB-PA05104B0Rb | Cusabio |
|
|
Description: A polyclonal antibody against ANAPC5. Recognizes ANAPC5 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA |